| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/24/1997 | CA2258242A1 Device for topical treatment of acne and its method of manufacture |
| 12/24/1997 | CA2257528A1 Human protein kinase c inhibitor homolog |
| 12/23/1997 | US5700928 Polynucleotide encoding saliva binding protein |
| 12/23/1997 | US5700823 Administering 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide or n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide |
| 12/23/1997 | US5700822 Treatment of platelet derived growth factor related disorders such as cancers |
| 12/23/1997 | US5700816 Antiarthritic agents |
| 12/23/1997 | US5700800 Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound |
| 12/23/1997 | US5700795 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of type II diabetes |
| 12/23/1997 | US5700675 Protein kinase required for Ras signal transduction |
| 12/23/1997 | US5700590 Infant formula; specified weight ratios of nucleotide equivalents |
| 12/23/1997 | US5700485 Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
| 12/23/1997 | US5700459 Polybase and polyacid, one of which is a polymer, active material comprising antiinflammatory agent, antibiotic, enzyme inhibitor |
| 12/18/1997 | WO1997047732A2 Hexameric fusion proteins and uses therefor |
| 12/18/1997 | WO1997047659A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides |
| 12/18/1997 | WO1997047319A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
| 12/18/1997 | WO1997047318A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
| 12/18/1997 | WO1997047296A2 Compositions comprising vanadium compounds for use in the treatment of proliferative disorders and arthropathies |
| 12/18/1997 | WO1997047292A1 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds |
| 12/18/1997 | WO1997047271A2 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 12/18/1997 | CA2258082A1 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 12/18/1997 | CA2257991A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
| 12/18/1997 | CA2257990A1 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds |
| 12/18/1997 | CA2257861A1 Hexameric fusion proteins and uses therefor |
| 12/17/1997 | EP0812913A2 HR-1 receptor, a receptor of the cytokine receptors family |
| 12/17/1997 | EP0812356A1 Prostate-specific membrane antigen and uses thereof |
| 12/17/1997 | EP0812208A1 Pharmaceutical compositions for controlled release of soluble receptors |
| 12/17/1997 | EP0812193A1 Pharmaceutical compositions containing a benzydamine or its salt and an antimicrobial agent |
| 12/17/1997 | EP0812190A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 12/17/1997 | EP0812184A1 Nitric oxide synthase inhibitors |
| 12/17/1997 | EP0706369B1 Stimulation of tanning by dna fragments |
| 12/17/1997 | EP0559845B1 Use of compounds in preventing endotoxin shock |
| 12/17/1997 | EP0458901B1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 12/16/1997 | US5698571 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
| 12/16/1997 | US5698530 A vaccinia virus into which carcinoembryonic antigen gene is inserteted; induce an active immune response |
| 12/16/1997 | US5698405 Coupling immunogenic agent with a carbohydrate polymer |
| 12/16/1997 | US5698232 Pharmaceutical composition for treatment of sudden deafness |
| 12/16/1997 | US5698224 Osmotic dosage form |
| 12/16/1997 | US5698214 Prevent glucose transfer into cells |
| 12/16/1997 | US5697902 Treating patient with antibody or antibody fragment conjugated to cytotoxic agent |
| 12/11/1997 | WO1997046688A1 Lipid kinase |
| 12/11/1997 | WO1997046686A2 Tumor necrosis factor-related polypeptide |
| 12/11/1997 | WO1997046683A2 Polynucleotides encoding secreted proteins |
| 12/11/1997 | WO1997046682A2 Polynucleotides from human adult pbmc encoding secreted proteins |
| 12/11/1997 | WO1997046257A1 A method for enhancing long-term memory in a subject and uses thereof |
| 12/11/1997 | WO1997046246A1 Complex preparations characterised by a betain content |
| 12/11/1997 | WO1997046243A1 A nasal spray containing an intranasal steroid and an antihistamine |
| 12/11/1997 | WO1997046239A1 Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists |
| 12/11/1997 | WO1997046231A1 Oxa acids and related compounds for treating skin conditions |
| 12/11/1997 | WO1997046226A2 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS |
| 12/11/1997 | WO1997041443A3 Method for screening compounds |
| 12/11/1997 | WO1997041252A3 Dna, rna and a protein useful for detection of a mycobacterial infection |
| 12/11/1997 | CA2257559A1 Complex preparations characterised by a betain content |
| 12/11/1997 | CA2257299A1 Use of inhibitors of the cellular na+/h+ exchanger (nhe) for production of a medicament for the normalization of serum lipids |
| 12/11/1997 | CA2257084A1 Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists |
| 12/11/1997 | CA2257074A1 A method for enhancing long-term memory in a subject and uses thereof |
| 12/11/1997 | CA2256721A1 A nasal spray containing an intranasal steroid and an antihistamine |
| 12/11/1997 | CA2256522A1 Polynucleotides encoding secreted proteins |
| 12/11/1997 | CA2256464A1 Tumor necrosis factor-related polypeptide |
| 12/10/1997 | EP0811696A2 Method to obtain nucleotide sequence using randomly primed amplification |
| 12/10/1997 | EP0811688A2 Staphylococcus aureus RNase P |
| 12/10/1997 | EP0811686A2 Human platelet-derived growth factor receptors |
| 12/10/1997 | EP0811685A2 Human platelet-derived growth factor receptors |
| 12/10/1997 | EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta |
| 12/10/1997 | EP0811159A1 A process for identifiying pharmaceutically active agents using an epitope-tagged library |
| 12/10/1997 | EP0811073A2 Methods and compositions for administering gene therapy vectors |
| 12/10/1997 | EP0811066A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 12/10/1997 | EP0811063A2 Chemokine receptors 88-2b ckr-3] and 88c and their antibodies |
| 12/10/1997 | EP0810884A1 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 12/10/1997 | EP0810879A1 Preparation and use of a specific gaba-aalpha5 receptor ligand for treatment of alzheimer's disease |
| 12/10/1997 | EP0810864A1 2,6-diaryl pyridazinones with immunosuppressant activity |
| 12/10/1997 | EP0810863A1 Method of treating adenosine depletion |
| 12/10/1997 | EP0810823A1 Composition for controlling parasites |
| 12/10/1997 | EP0417209B1 Compositions and methods for administering therapeutically active compounds |
| 12/10/1997 | CN1167442A Composition for prevention and treatment of HIV-1 infection comprising at least two different HIV-1 reverse transcriptase inhibitors |
| 12/10/1997 | CN1167440A Immunotherapeutic stress protein-peptide complexes against cancer |
| 12/09/1997 | US5696298 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 12/09/1997 | US5696270 Intermediate for making retroviral protease inhibiting compounds |
| 12/09/1997 | US5696164 Antifungal treatment of nails |
| 12/09/1997 | US5696160 Topical composition enhancing healing of viral lesions |
| 12/09/1997 | US5696147 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| 12/09/1997 | US5696135 Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
| 12/09/1997 | US5696128 Adjustment prolactin profile |
| 12/09/1997 | US5696116 Pharmaceutical composition which contains a renin angiotensin system inhibitor and an endothelin antagonist |
| 12/09/1997 | US5696114 Treatment and prevention of odema |
| 12/09/1997 | US5696101 Oxidized cellulose and vitamin E blend for topical hemostatic applications |
| 12/09/1997 | US5696099 Topical preparations for the treatment of acne and acneiform dermatitis |
| 12/09/1997 | US5695932 Telomerase activity assays for diagnosing pathogenic infections |
| 12/09/1997 | US5695755 Peripheralization of hematopoietic stem cells |
| 12/04/1997 | WO1997045735A1 Method for monitoring t-cell reactivity |
| 12/04/1997 | WO1997045528A2 Mammalian tolloid-like gene and protein |
| 12/04/1997 | WO1997045447A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS |
| 12/04/1997 | WO1997045412A1 A method of treating cancer |
| 12/04/1997 | WO1997045143A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 12/04/1997 | WO1997045141A1 Remedy for autoimmune diseases |
| 12/04/1997 | WO1997045138A1 New improved formulation for treatment of thromboembolism |
| 12/04/1997 | WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis |
| 12/04/1997 | WO1997045113A1 Nsaids for regulating the reproductive cycle of domesticated animals |
| 12/04/1997 | WO1997045105A1 Compositions and methods for treating or preventing diseases of body passageways |
| 12/04/1997 | WO1997039749A3 Method for the prevention and treatment of cachexia and anorexia |
| 12/04/1997 | WO1997038689A3 Enteric-coated pharmaceutical compositions of mycophenolate |